Patentability of Life Science Inventions: A comparison between European and US Practice in Biopharma Business

In this webinar, Dr. Luke Buchanan, an experienced patent attorney, will shine light on the subtle differences of EU vs. US Patent law, utilizing a variety of real-world examples.

Zoom

SPARK Europe Webinar Series | 1 June 2022 |4-5 pm (CET)
Dr. Luke Buchanan “Patentability of Life Science Inventions: A comparison between European and US Practice in Biopharma Business”

Are you working on an innovative technology and wondering if it is patentable in the EU or the States? And what are the differences in regulations between the European Patent office (EPO) and United States Patent and Trademark Office (USPTO)?
In this webinar, Dr. Luke Buchanan, an experienced patent attorney, will shine light on the subtle differences of EU vs. US Patent law, utilizing a variety of real-world examples and teaching us:
• Basic patentability requirements
• Comparison between patent eligibility with the EPO and USPTO
• Enablement Requirements for biotech inventions with the EPO and USPTO
• Examples: Diagnostic and Therapeutic Inventions

Online via Zoom ǀ Please register here!
Registration to the webinar is required in advance. Please register no later than May 31st 2022.

This webinar will be hosted by SPARK-FLI.

SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.

SPARK-BIH is a member of the SPARK Global network